ANSORGE SIEGFRIED has a total of 19 patent applications. Its first patent ever was published in 2001. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and materials and metallurgy are PFIZER PRODUCTS INC., PARATEK PHARM INNC and POSEIDON PHARMACEUTICALS AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 9 | |
#2 | United States | 8 | |
#3 | Australia | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Materials and metallurgy | |
#4 | Measurement | |
#5 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Ansorge Siegfried | 19 |
#2 | Taeger Michael | 12 |
#3 | Bank Ute | 10 |
#4 | Striggow Frank | 10 |
#5 | Nordhoff Karsten | 9 |
#6 | Neubert Klaus | 7 |
#7 | Lendeckel Uwe | 7 |
#8 | Reinhold Dirk | 3 |
#9 | Gollnick Harald | 3 |
#10 | Vetter Robert | 3 |
Publication | Filing date | Title |
---|---|---|
AU2003214105A2 | Use of enzyme inhibitors with aminopeptidase N and/or dipeptidylpeptidase IV activities and pharmaceutical preparations produced therefrom for the therapy and prevention of dermatological diseases with seborrhoeic hyperproliferation and altered differentiation states | |
AU2002234598A1 | Use of dipeptylpeptidase iv and aminopeptidase-n inhibitors in the treatment of ischaemia-induced neuro-degeneration |